These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4104301)

  • 21. [Use of Transamine, new antifibrinolytic agent. Its use in gynecology, obstetrics and surgery].
    Lemgruber I; Maywald V
    Hospital (Rio J); 1970 Jan; 77(1):107-18. PubMed ID: 5309987
    [No Abstract]   [Full Text] [Related]  

  • 22. [The postoperative hemorrhage in the prostate surgery].
    Lennert KA; Hepp G
    Bruns Beitr Klin Chir (1971); 1967 Nov; 215(3):313-20. PubMed ID: 4172497
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
    Bramsen T
    Acta Ophthalmol Suppl; 1980; (145):1-53. PubMed ID: 6257028
    [No Abstract]   [Full Text] [Related]  

  • 24. Control of bleeding during and after prostatectomy.
    Fam A
    Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
    [No Abstract]   [Full Text] [Related]  

  • 25. [Postoperative bleeding prevention: results of combined bleeding and anti-coagulant prevention after vaginal surgery].
    Herschlein HJ; Steichele DF
    Geburtshilfe Frauenheilkd; 1971 Jan; 31(1):62-8. PubMed ID: 5540994
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of tissue hemorrhage following conization of the cervix uteri using antifibrinolytics].
    Koutský J; Rybák M; Kraus I; Kanka J; Svoboda B
    Zentralbl Gynakol; 1974 Nov; 96(46):1455-9. PubMed ID: 4454791
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of obstetric bleeding with antifibrinolytics.
    Isaksson G
    Cent Afr J Med; 1973 May; 19(5):98. PubMed ID: 4541738
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemophilia].
    Maekawa T; Kobayashi N; Ryu R
    Naika; 1971 Jun; 27(6):1333-7. PubMed ID: 4326413
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical use of transamin in pharyngeal diseases].
    Horiguchi S; Tanaka S; Ichikawa S
    Jibiinkoka; 1969 May; 41(5):375-9. PubMed ID: 4898436
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.
    Gibbs JR; Corkill AG
    Postgrad Med J; 1971 Apr; 47(546):199-200. PubMed ID: 5576488
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of EACA, AMCHA and guanethidine on metastases induced by intravenously injected tumour cells.
    Boeryd B; Hagmar B; Johnsson G; Ryd W
    Pathol Eur; 1974; 9(2):119-23. PubMed ID: 4437956
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experiences with p-aminomethylbenzoic acid (PAMBA) in severe acute fibrinolytic hemorrhage in internal medicine].
    Sundermann A; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):22-31. PubMed ID: 4173877
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 35. Tranexamic acid in the control of spontaneous bleeding in severe haemophilia.
    Rainsford SG; Jouhar AJ; Hall A
    Thromb Diath Haemorrh; 1973 Nov; 30(2):272-9. PubMed ID: 4773366
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fibrinolytic hemorrhage in surgery and its treatment with p-aminomethylbenzoic acid].
    Hellinger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):32-40. PubMed ID: 4173878
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1973 Jul; 14(4):335-49. PubMed ID: 4542948
    [No Abstract]   [Full Text] [Related]  

  • 38. A bleeding tongue - acute presentation of fibrinolysis.
    Hodson A; Hunt BJ
    Int J Lab Hematol; 2007 Oct; 29(5):393-4. PubMed ID: 17824923
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antifibrinolytic agents and their therapeutic use].
    Fischer M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):64-77. PubMed ID: 4189375
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent trends in antifibrinolytic therapy.
    Menon IS
    Br J Clin Pract; 1967 Aug; 21(8):405-8. PubMed ID: 6076264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.